CMR Surgical

Executive Summary

CMR Surgical, based in Cambridge, UK, is a private company developing Versius, a modular and portable surgical robot designed to democratize minimal access surgery. Founded in 2014, the company aims to make robotic surgery more accessible by reducing cost and footprint compared to legacy systems like da Vinci. Versius’s modular design allows for flexible configuration and easy integration into existing operating rooms, potentially expanding robotic surgery to more hospitals and procedures globally. The company has raised significant capital (though exact amounts are not disclosed) from investors including LGT, Escala Capital, and Cambridge Innovation Capital. CMR Surgical has received CE mark approval for Versius in Europe and has been expanding its commercial footprint, particularly in Europe, Asia, and Latin America. Key challenges include gaining FDA clearance for the U.S. market, competing with established players like Intuitive Surgical, and demonstrating clinical and economic value at scale. If successful, Versius could capture a meaningful share of the growing surgical robotics market, which is expected to exceed $20 billion by 2030.

Upcoming Catalysts (preview)

• 2027FDA Clearance for Versius70% success
• Q3 2026Major Commercial Partnership or Distribution Deal in Asia60% success
• TBDSeries E or IPO Announcement50% success